These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19548885)

  • 81. Effect of Fluoroquinolone Use in Primary Care on the Development and Gradual Decay of
    Kurotschka PK; Fulgenzio C; Da Cas R; Traversa G; Ferrante G; Massidda O; Gágyor I; Aschbacher R; Moser V; Pagani E; Spila Alegiani S; Massari M
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740228
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use.
    Lautenbach E; Larosa LA; Kasbekar N; Peng HP; Maniglia RJ; Fishman NO
    Arch Intern Med; 2003 Mar; 163(5):601-5. PubMed ID: 12622607
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Increasing Rates of Fluoroquinolone Resistance in
    Hauck CG; Chong PP; Miller MB; Jamieson K; Fine JP; Foster MC; Shea TC; van Duin D
    Pathog Immun; 2016; 1(2):234-242. PubMed ID: 28004038
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Concentrations of Ciprofloxacin in the World's Rivers Are Associated with the Prevalence of Fluoroquinolone Resistance in
    Kenyon C
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326880
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Genomic Profiling of Antibiotic-Resistant
    Magaña-Lizárraga JA; Gómez-Gil B; Rendón-Maldonado JG; Delgado-Vargas F; Vega-López IF; Báez-Flores ME
    Microorganisms; 2022 Mar; 10(3):. PubMed ID: 35336237
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance.
    Shriram V; Khare T; Bhagwat R; Shukla R; Kumar V
    Front Microbiol; 2018; 9():2990. PubMed ID: 30619113
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
    Ramírez-Castillo FY; Moreno-Flores AC; Avelar-González FJ; Márquez-Díaz F; Harel J; Guerrero-Barrera AL
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):34. PubMed ID: 30041652
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tracking Change: A Look at the Ecological Footprint of Antibiotics and Antimicrobial Resistance.
    Keen PL; Patrick DM
    Antibiotics (Basel); 2013 Mar; 2(2):191-205. PubMed ID: 27029298
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characterization of Escherichia coli Isolates from an Urban Lake Receiving Water from a Wastewater Treatment Plant in Mexico City: Fecal Pollution and Antibiotic Resistance.
    Rosas I; Salinas E; Martínez L; Cruz-Córdova A; González-Pedrajo B; Espinosa N; Amábile-Cuevas CF
    Curr Microbiol; 2015 Oct; 71(4):490-5. PubMed ID: 26198413
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Resistance to antibiotics of clinical relevance in the fecal microbiota of Mexican wildlife.
    Cristóbal-Azkarate J; Dunn JC; Day JM; Amábile-Cuevas CF
    PLoS One; 2014; 9(9):e107719. PubMed ID: 25233089
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Presence of multi-drug resistant pathogenic Escherichia coli in the San Pedro River located in the State of Aguascalientes, Mexico.
    Ramírez Castillo FY; Avelar González FJ; Garneau P; Márquez Díaz F; Guerrero Barrera AL; Harel J
    Front Microbiol; 2013; 4():147. PubMed ID: 23785356
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Biological and physicochemical wastewater treatment processes reduce the prevalence of virulent Escherichia coli.
    Frigon D; Biswal BK; Mazza A; Masson L; Gehr R
    Appl Environ Microbiol; 2013 Feb; 79(3):835-44. PubMed ID: 23160132
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
    Nikaido H; Pagès JM
    FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

  • 95. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Fluoroquinolone resistance in clinical and environmental isolates of Escherichia coli in Mexico City.
    Amábile-Cuevas CF; Arredondo-García JL; Cruz A; Rosas I
    J Appl Microbiol; 2010 Jan; 108(1):158-62. PubMed ID: 19548885
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates].
    Coban AY; Birinci A; Ekinci B; Durupinar B
    Mikrobiyol Bul; 2004; 38(1-2):21-5. PubMed ID: 15293898
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.